Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Multi Bintang Indonesia Tbk. (MLBI) Price & Performance

UBC Medical Indonesia Tbk.Trade
Multi Bintang Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Multi Bintang Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Multi Bintang Indonesia Tbk. trades at Rp6,325 (market cap 13.33T, 51.1K 24h volume). The key difference: Multi Bintang Indonesia Tbk. is far larger — about 23.1× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 51.1K). Which is the better fit depends on your goals.

LABSMLBI
Market Cap
576.7B13.33T
Volume
3.48M51.1K
Lot
34.82K511
Turnover
522.79M322.91M
Average Price
150.136,319.08
Value
522.79M322.91M
Indicative Equilibrium Price
148
Indicative Equilibrium Volume
350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MLBI
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Multi Bintang Indonesia Tbk.

PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).

Read more on MLBI